Key result
Expanded-polytetrafluoroethylene mitral chordae implantation in 51 patients resulted in 41 patients achieving NYHA Class I and 3 in Class II at a mean follow-up of 20 months.
Why the study?
Does implantation of expanded-polytetrafluoroethylene mitral chordae improve clinical outcomes in patients undergoing mitral valve repair?
Observational (n=51)
Does implantation of expanded-polytetrafluoroethylene mitral chordae improve clinical outcomes in patients undergoing mitral valve repair?
The use of expanded-polytetrafluoroethylene for artificial mitral chordae implantation is a feasible technique that yields good functional outcomes in patients undergoing mitral valve repair.
No takes yet. Share an insight, caveat, or question.
Supports ePTFE chordae in mitral repair; hypothesis-generating and requires prospective validation.
Zussa et al. (1991) conducted an observational in Mitral valve disease (n=51). Expanded-polytetrafluoroethylene mitral chordae implantation was evaluated. Expanded-polytetrafluoroethylene mitral chordae implantation in 51 patients resulted in 41 patients achieving NYHA Class I and 3 in Class II at a mean follow-up of 20 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: